Correspondence 0001104659-24-064154 from Inhibrx Biosciences, Inc. (INBX) (CIK 0002007919) (INBX)

Inhibrx Biosciences, Inc. (INBX) (CIK 0002007919)
Date: May 22, 2024 · CIK: 0002007919 · Accession: 0001104659-24-064154

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-42031

Date

May 22, 2024

Author

Form

CORRESP

Company

Inhibrx Biosciences, Inc. (INBX) (CIK 0002007919)

Letter

VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Attention: Jimmy McNamara and Suzanne Hayes Re: Inhibrx Biosciences, Inc. Form 10-12B File No. 001-42031

Dear Mr. McNamara and Ms. Hayes:

In accordance with Rule 12d1-2 promulgated under the Securities Exchange Act of 1934, as amended, Inhibrx Biosciences, Inc. hereby respectfully requests that the effective date of its Registration Statement on Form 10 (File No. 001-42031) (the “Registration Statement”) be accelerated by the Securities and Exchange Commission to 3:00 p.m., New York City time, on May 24, 2024, or as soon thereafter as practicable.

It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Brian M. Janson at (212) 373-3588, with written confirmation sent to the address listed on the cover of the Registration Statement to follow.

Sincerely,
INHIBRX BIOSCIENCES, INC.

Show Raw Text

CORRESP
1
filename1.htm

INHIBRX BIOSCIENCES, INC.

11025 N. Torrey Pines Road, Suite 140

La Jolla, CA 92037

May 22, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention:             Jimmy McNamara and Suzanne Hayes

 Re: Inhibrx Biosciences, Inc.

Form 10-12B

File No. 001-42031

Dear Mr. McNamara and Ms. Hayes:

In accordance with Rule 12d1-2 promulgated under
the Securities Exchange Act of 1934, as amended, Inhibrx Biosciences, Inc. hereby respectfully requests that the effective date
of its Registration Statement on Form 10 (File No. 001-42031) (the “Registration Statement”) be accelerated
by the Securities and Exchange Commission to 3:00 p.m., New York City time, on May 24, 2024, or as soon thereafter as practicable.

It would be appreciated if, as soon as the Registration
Statement is declared effective, you would so inform Brian M. Janson at (212) 373-3588, with written confirmation sent to the
address listed on the cover of the Registration Statement to follow.

    Sincerely,

    INHIBRX BIOSCIENCES, INC.

    By:
    /s/ Kelly Deck

    Name:
    Kelly Deck

    Title:
    Chief Financial Officer

SecProbe.io